Mackay Shields LLC Gilead Sciences, Inc. Transaction History

Mackay Shields LLC

$581 Million
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 03, 2022	SELL	$57.72 - $65.01 $10.5 Million - $11.8 Million	-181,555 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$57.92 - $72.58 $410,652 - $514,592	-7,090 Reduced 3.76%	181,555 $10.8 Million
Q4 2021 Feb 04, 2022	SELL	$64.88 - $73.64 $288,261 - $327,182	-4,443 Reduced 2.3%	188,645 $13.7 Million
Q3 2021 Nov 12, 2021	SELL	$67.69 - $73.03 $365,593 - $394,435	-5,401 Reduced 2.72%	193,088 $13.5 Million
Q2 2021 Aug 13, 2021	SELL	$63.47 - $69.35 $7.01 Million - $7.66 Million	-110,524 Reduced 35.77%	198,489 $13.7 Million
Q1 2021 May 14, 2021	SELL	$60.0 - $68.46 $5.43 Million - $6.2 Million	-90,571 Reduced 22.67%	309,013 $20 Million
Q4 2020 Feb 16, 2021	BUY	$56.65 - $64.55 $1.66 Million - $1.89 Million	29,220 Added 7.89%	399,584 $23.3 Million
Q3 2020 Nov 04, 2020	SELL	$62.1 - $78.08 $3.66 Million - $4.6 Million	-58,894 Reduced 13.72%	370,364 $23.4 Million
Q2 2020 Jul 31, 2020	BUY	$72.34 - $84.0 $7.82 Million - $9.07 Million	108,033 Added 33.63%	429,258 $33 Million
Q1 2020 May 08, 2020	SELL	$62.63 - $80.22 $15 Million - $19.2 Million	-239,325 Reduced 42.69%	321,225 $24 Million
Q4 2019 Feb 11, 2020	SELL	$61.62 - $67.78 $54,718 - $60,188	-888 Reduced 0.16%	560,550 $36.4 Million
Q3 2019 Nov 01, 2019	SELL	$62.51 - $69.0 $465,449 - $513,774	-7,446 Reduced 1.31%	561,438 $35.6 Million
Q2 2019 Aug 13, 2019	SELL	$61.87 - $69.38 $6.99 Million - $7.84 Million	-113,015 Reduced 16.57%	568,884 $38.4 Million
Q1 2019 May 13, 2019	BUY	$62.53 - $70.05 $2.02 Million - $2.26 Million	32,248 Added 4.96%	681,899 $44.3 Million
Q4 2018 Feb 14, 2019	SELL	$60.54 - $79.0 $12.3 Million - $16.1 Million	-203,393 Reduced 23.84%	649,651 $40.6 Million
Q3 2018 Nov 14, 2018	BUY	$71.28 - $78.92 $8.11 Million - $8.98 Million	113,752 Added 15.39%	853,044 $65.9 Million
Q2 2018 Aug 06, 2018	BUY	$64.88 - $75.68 $670,599 - $782,228	10,336 Added 1.42%	739,292 $52.4 Million
Q1 2018 May 03, 2018	BUY	$72.84 - $88.8 $53.1 Million - $64.7 Million	728,956 New	728,956 $55 Million

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$11.1 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.7 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$7.07 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.71 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.56 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mackay Shields LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mackay Shields LLC with notifications on news.

Account